Tumor-specific activation of prodrugs: is there a role for nuclear medicine?

被引：2

作者：

Antunes, Ines F. ^{[1
]}

Haisma, Hidde J. ^{[2
]}

de Vries, Erik F. J. ^{[1
]}

机构：

[1] Univ Med Ctr Groningen, Dept Nucl Med & Mol Imaging, NL-9713 GZ Groningen, Netherlands

[2] Univ Groningen, Univ Ctr Pharm, Dept Therapeut Gene Modulat, Groningen, Netherlands

来源：

关键词：

D O I：

10.1097/MNM.0b013e3283094efc

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

引用

页码：845 / 846

页数：2

共 21 条

[1] Radiolabelled tracers and anticancer drugs for assessment of therapeutic efficacy using PET
Brady, F
Luthra, SK
Brown, GD
Osman, S
Aboagye, E
Saleem, A
Price, PM
[J]. CURRENT PHARMACEUTICAL DESIGN, 2001, 7 (18) : 1863 - 1892
[2] Chen Xi, 2003, Current Medicinal Chemistry - Anti-Cancer Agents, V3, P139, DOI 10.2174/1568011033353470
[3] Dachs GU, 1997, ONCOL RES, V9, P313
[4] Pronounced antitumor efficacy by extracellular activation of a doxorubicin-glucuronide prodrug after adenoviral vector-mediated expression of a human antibody-enzyme fusion protein
De Graaf, M
Pinedo, HM
Oosterhoff, D
Van der Meulen-Muileman, IH
Gerritsen, WR
Haisma, HJ
Boven, E
[J]. HUMAN GENE THERAPY, 2004, 15 (03) : 229 - 238
[5] de Graaf M, 2002, CURR PHARM DESIGN, V8, P1391
[6] de Groot FMH, 2001, CURR MED CHEM, V8, P1093
[7] Scintigraphic imaging of HSVtk gene therapy
de Vries, EFJ
Buursma, AR
Hospers, GAP
Mulder, NH
Vaalburg, W
[J]. CURRENT PHARMACEUTICAL DESIGN, 2002, 8 (16) : 1435 - 1450
[8] A gadolinium chelate for detection of β-glucuronidase:: A self-immolative approach
Duimstra, JA
Femia, FJ
Meade, TJ
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (37) : 12847 - 12855
[9] Greco O, 2001, J CELL PHYSIOL, V187, P22, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1060>3.0.CO
[10] 2-H